MAP2K7 and pancreatic ductal adenocarcinoma: A recent preclinical mouse study and clinical trial suggest that targeting autophagy with chloroquine (CQ) increases the sensitivity of pancreatic ductal adenocarcinoma (PDAC) to MEK inhibition [29, 57].